Glipizide Tablet, Film Coated, Extended Release
Product Images NDC 51655-966

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 51655-966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

51655-966-52 (51655 966 52 Rev A 06 23)

51655-966-52 (51655 966 52 Rev A 06 23)
This is a description for a medication called glipiZIDE, which is available in extended-release tablet form. Each tablet contains 10mg of the active ingredient. The tablets are prescribed for use under medical supervision. The medication should be stored at a temperature between 20°C and 25°C (68°F - 77°F) according to the USP guidelines. It is important to keep the medication out of reach of children and store it in the original container to protect it from moisture and humidity. The medication has been repackaged by Northwind Pharmaceuticals and the original manufacturer is Rising Pharmaceuticals, Inc. The GTIN (Global Trade Item Number) is 00351655966525. The lot number is 0000000000. The expiration date is 00/00/0000.*
FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.